Supplemental material
Cancer Biology & Therapy
Volume 22, 2021 - Issue 10-12
Research Paper
Antitumorigenic effect of combination treatment with ONC201 and TRAIL in endometrial cancer in vitro and in vivo
, 
, , , , & show all
Marie D. Ralffa Laboratory of Translational Oncology and Experimental Cancer Therapeutics, Department of Medical Oncology and Molecular Therapeutics Program, Fox Chase Cancer Center, Philadelphia, PA, USA;c MD/PhD Program, the Lewis Katz School of Medicine, Temple University, Philadelphia, PA, USAhttps://orcid.org/0000-0003-2113-0974View further author information
https://orcid.org/0000-0003-2113-0974View further author information, , , , & Wafik S. El-Deirya Laboratory of Translational Oncology and Experimental Cancer Therapeutics, Department of Medical Oncology and Molecular Therapeutics Program, Fox Chase Cancer Center, Philadelphia, PA, USA;e Joint Program in Cancer Biology, Brown University and the Lifespan Health System, Providence, RI, USA;f Laboratory of Translational Oncology and Experimental Cancer Therapeutics, Department of Pathology and Laboratory Medicine, The Warren Alpert Medical School, Brown University, Providence, RI, USA;g Cancer Center at Brown University, the Warren Alpert Medical School, Brown University, Providence, RI, USA;i Brown University and the Lifespan Cancer Institute, Providence, RI, USACorrespondence[email protected]
https://orcid.org/0000-0002-9577-8266View further author information
https://orcid.org/0000-0002-9577-8266View further author information show all